|
Post by nylefty on Feb 8, 2019 15:54:01 GMT -5
Yes what is mnkd doing to target it’s message to mellenials and pwd in their late teens, early 20’s to 30’s. They are the tech savvy new adopters! Not sure they are watching CNN, Fox et al... this is where they should run ads on college campus networks, and fb, social media etc... Young people have told me that Facebook is now mostly for "older people" (like their parents and grandparents). Most of my Facebook Friends are in their 70s or 80s (like me).
|
|
|
Post by mytakeonit on Feb 8, 2019 16:00:30 GMT -5
Oh no ... now you will be listed on peppy's notebook ... as being an old fart.
|
|
|
Post by mnkdfann on Feb 8, 2019 16:52:25 GMT -5
Yes what is mnkd doing to target it’s message to mellenials and pwd in their late teens, early 20’s to 30’s. They are the tech savvy new adopters! Not sure they are watching CNN, Fox et al... this is where they should run ads on college campus networks, and fb, social media etc... Young people have told me that Facebook is now mostly for "older people" (like their parents and grandparents). Most of my Facebook Friends are in their 70s or 80s (like me). I have 30-year old relatives (nieces, nephews, and the like) and they are far more active on Facebook than I ever was. I'd say Facebook is still popular among those who were, say, 12 years and over about 15 years ago when Facebook started up. In my experience, people around age 30 and up are still active there. Under age 25, that is a different story. I think they gravitate more to Instagram, Snap, Twitter, Youtube, and such. This is in the U.K., but I think it probably (evidently according to the article) more or less applies in the U.S. as well: www.dailymail.co.uk/sciencetech/article-6105279/Snapchat-surges-popularity-people-turn-backs-Facebook-UK.html
|
|
|
Post by mannmade on Feb 8, 2019 17:00:07 GMT -5
Regardless where is the social media campaign geared to them!
|
|
|
Post by joeypotsandpans on Feb 8, 2019 18:50:10 GMT -5
Unfortunately, this endo is actually up-to-date when s/he states that Afrezza delivers less control than a pump. Why? Because there have been ZERO publications by MannKind in major medical journals to dispute what this endocrinologist has learned about inhaled insulin. The STAT results were published in by Kartish Garg MD in his diabetes journal, which has a smaller readership than Lancet, AMA or NEJM. This lack of current and available medical information is kicking MannKind in the rear end, IMO. For all the money being spent on DTC ads for Afrezza, what good will it do if the doctors refuse to prescribe it? Where are the new publications that Castagna/Kendall stated would soon be released? I believe the statement about upcoming medical publications was made at either the Cantor Fitzgerald Global Healthcare Conference on Oct 2, 2018 or the Rodman & Renshaw 20th Annual Global Investment Conference on Sept 5, 2018. There are two mindsets, status quo and progressive. One is the "safe" way forward and the other is more "proactive". If you recall, I had seen a couple of primary care physicians NP's and PA's both had no real clue about Afrezza, the primary care I currently have was much more open minded and good in setting up a referral to my current endo, visited two in the beginning so great comparison. While the one through Southwest Medical (tied in with UHC arm Optum) was interested in my story and results with Afrezza, UHC was a no go. Enter my current and ongoing endo, and for any of those in the Las Vegas area Las Vegas Endocrinology, specifically Dr.Nguyen has been on board since the early days of Sanofi. The original SNY rep I use to refer in my posts had informed me that he was a huge advocate and believer in the product and science behind it. So hence, requested my new primary for the referral and the rest was history. What's also really progressive with him is he is a teaching practice and has quite a few students rotating through his practice. So it's nice to know he's teaching them the advantages and benefits of Afrezza. Just thought I'd mention this as all hope is not lost, unfortunately he's probably in the minority of those that are more proactive in understanding the disease and how best to care for his patients...he really is a rare type of physician IMO. I am lucky to have gotten in with him
|
|
|
Post by lakers on Feb 8, 2019 18:50:57 GMT -5
|
|